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ABSTRACT
Objectives  Systemic lupus erythematosus (SLE) is a 
chronic multisystem genetically complex autoimmune 
disease characterised by the production of autoantibodies to 
nuclear and cellular antigens, tissue inﬂ  ammation and organ 
damage. Genome-wide association studies have shown 
that variants within the major histocompatibility complex 
(MHC) region on chromosome 6 confer the greatest genetic 
risk for SLE in European and Chinese populations. However, 
the causal variants remain elusive due to tight linkage 
disequilibrium across disease-associated MHC haplotypes, 
the highly polymorphic nature of many MHC genes and the 
heterogeneity of the SLE phenotype.
Methods  A high-density case-control single nucleotide 
polymorphism (SNP) study of the MHC region was 
undertaken in SLE cohorts of Spanish and Filipino 
ancestry using a custom Illumina chip in order to ﬁ  ne-
map association signals in these haplotypically diverse 
populations. In addition, comparative analyses were 
performed between these two datasets and a northern 
European UK SLE cohort. A total of 1433 cases and 1458 
matched controls were examined.
Results  Using this transancestral SNP mapping approach, 
novel independent loci were identiﬁ  ed within the MHC 
region in UK, Spanish and Filipino patients with SLE with 
some evidence of interaction. These loci include HLA-DPB1, 
HLA-G and MSH5 which are independent of each other 
and HLA-DRB1 alleles. Furthermore, the established SLE-
associated HLA-DRB1*15 signal was reﬁ  ned to an interval 
encompassing HLA-DRB1 and HLA-DQA1. Increased 
frequencies of MHC region risk alleles and haplotypes were 
found in the Filipino population compared with Europeans, 
suggesting that the greater disease burden in non-
European SLE may be due in part to this phenomenon.
Conclusion  These data highlight the usefulness of 
mapping disease susceptibility loci using a transancestral 
approach, particularly in a region as complex as the 
MHC, and offer a springboard for further ﬁ  ne-mapping, 
resequencing and transcriptomic analysis.
INTRODUCTION
Systemic lupus erythematosus (SLE) is a chronic 
multisystem autoimmune disease characterised by 
the production of autoantibodies to nuclear and 
cellular antigens, tissue inﬂ   ammation and organ 
damage. There is a strong but complex genetic 
component to SLE susceptibility, whereby many 
polymorphisms each with a small or modest effect 
contribute to disease susceptibility. Genome-wide 
association studies have shown that variants within 
the major histocompatibility complex (MHC) region 
on chromosome 6 confer the greatest genetic risk 
for SLE in European and Chinese populations.1–3 
The extended MHC spans almost 8 Mb and is 
divided into ﬁ  ve subregions: extended class I (telo-
meric), class I, class III, class II and extended class 
II (centromeric). One of the most complex regions 
of the genome, this locus harbours two copy vari-
able regions (the HLA-DRB genes in class II and the 
RCCX module containing complement component 
C4 in class III), some of the most polymorphic genes 
in the genome and conserved haplotypes where 
linkage disequilibrium (LD) extends over 2 Mb in 
some instances. The region has been the subject 
of extensive study given the importance of MHC 
alleles in the pathogenesis of tissue incompatibil-
ity, drug sensitivity, autoimmune, infectious and 
inﬂ  ammatory diseases.
In European SLE cohorts, well-established asso-
ciations are observed with highly conserved and 
extended haplotypes bearing the class II alleles 
HLA-DRB1*03:01 and HLA-DRB1*15:01.4 More 
recent high-density single nucleotide polymor-
phism (SNP) genotyping studies have demonstrated 
multiple independent signals across the MHC in 
northern European cohorts.5 6 However, the causal 
variants remain elusive due to tight LD across 
disease-associated MHC haplotypes, the highly 
polymorphic nature of associated variants and the 
heterogeneity of the SLE phenotype. Fine-mapping 
studies across the MHC region in other European 
and non-European SLE populations are lacking. The 
haplotypic diversity consequent on differing ances-
try and environment demonstrated by these popu-
lations at the MHC region as well as non-MHC loci 
should allow further reﬁ  nement of known asso-
ciation signals together with the identiﬁ  cation of 
novel susceptibility variants. Given these known 
haplotypic differences, we undertook a high-den-
sity case-control SNP study of the MHC region in 
SLE cohorts of Spanish and Filipino ancestry using 
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UK cohort
The cohort comprised 632 SLE probands and 742 unrelated con-
trols from a previous study.5
All SLE probands fulﬁ   lled the American College of 
Rheumatology criteria for the classiﬁ   cation of SLE.7 Written 
consent was obtained from all study participants.
Sample collection
DNA was obtained from whole blood using phenol-chloroform 
extraction. Native genomic DNA was used for the Spanish 
study. For the Filipino cohort, 100 ng (5 μl at 20 ng/μl) native 
DNA was whole genome ampliﬁ  ed using the Qiagen REPLI-g 
Midi Kit (Cat. No. 150045) according to the manufacturer’s writ-
ten instructions.
Custom iSelect Illumina SNP array and genotyping
The samples were genotyped at the Feinstein Institute, USA 
using a custom Illumina iSelect chip comprising 10 788 SNPs: 
6045 SNPs within the MHC region (29–33.5 Mb) and 4743 SNPs 
informative for major and European ancestry (see online supple-
ment for SNP selection criteria).8 9
a custom Illumina chip in order to ﬁ  ne-map established asso-
ciation signals and potentially uncover novel susceptibility loci. 
In addition, we have performed comparative analyses between 
these two datasets and a northern European UK SLE cohort. In 
total we examined 1433 cases and 1458 matched controls.
METHODS
Spanish cohort
The cohort comprised 464 cases and 468 controls. All cases were 
recruited from rheumatology clinics throughout Spain. Control 
samples were obtained from the Blood Bank Units of the hospi-
tals where the cases originated.
Filipino cohort
The cohort comprised 335 SLE probands and 247 unrelated 
controls. We also included 26 trios (father, mother and affected 
child) to allow checks for Mendelian inheritance. All probands 
attended the Rheumatology and Clinical Immunology Clinics 
at the University of Santo Tomas Hospital, Manila, Philippines. 
Unrelated controls were recruited from spouses and acquain-
tances of the probands.
Figure 1  High-density transancestral single nucleotide polymorphism (SNP) mapping of the major histocompatibility complex (MHC) region in UK, 
Spanish and Filipino systemic lupus erythematosus (SLE). The panels show MHC region association plots for (A) UK, (B) Spanish and (C) Filipino SLE 
cohorts where genomic position (Mb) is shown on the horizontal axis with –log10 p values on the vertical axis. The black squares represent genotyped 
SNPs and the blue squares indicate imputed SNPs in the UK cohort. The red squares represent classically typed HLA alleles in the UK (HLA-DRB1 
only) and Spanish (HLA-B, HLA-DRB1 and HLA-DQB1) cohorts. The panels beneath each association plot demonstrate the recombination rate for 
each cohort calculated using control haplotypes only generated with the program rhomap.27 A scaled map of the MHC region with relevant genes 
is shown in the bottom panel. RCCX represents the copy variable RCCX module containing the complement C4 gene (R=RP1/STK19, C=C4A/C4B, 
C=CYP21A2/CYP21A1P, X=TNXA/TNXB).
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were excluded if they were outliers on principal components 
analysis using post-QC AIMs (performed using EIGENSTRAT 
and deﬁ  ned as >4 SDs from the mean)11 (failed Spanish n=62, 
Filipino n=88). The genomic inﬂ  ation factor (λGC) was calculated 
using the post-QC AIMs after correction for population stratiﬁ  -
cation (Spanish λGC=1.04 and Filipino λGC=1.09).
UK SLE cohort imputation
Genotypes were imputed using IMPUTE12 on the initial set of 
directly genotyped SNPs (n=1230) up to the Wellcome Trust 
Case-Control Consortium 2 (WTCCC2) study (n=7119). The 
WTCCC2 data were used as reference genotypes in the impu-
tation, with dbsnp build 126 deﬁ  ning the genome map.13 No 
reference haplotypes were used in the imputation. Of the 7119 
imputed SNPs in the UK SLE cohort, 3314 overlapped with the 
6045 MHC SNPs genotyped in the Spanish and Filipino cohorts 
in this study and were used for analysis.
Statistical analyses
Single marker association analyses using logistic regression 
and stepwise logistic regression analyses were performed 
using PLINK and SNPTEST.14 We took the genotypes for the 
most associated SNP as a covariate and conditioned on this in 
the search for other independently associated SNPs in each 
dataset. If this analysis yielded further SNPs that passed our 
threshold of signiﬁ  cance (see below), we added the top SNP 
to further stepwise logistic regression models and continued 
the process until no further SNPs passed our threshold of sig-
niﬁ   cance. Haplotypic association analyses were performed 
using PLINK and R statistical package. Data for SNP rs409558 
in the Spanish and Filipino cohorts were meta-analysed using 
HLA genotyping
All HLA typing was performed using Luminex One Lambda 
SSO. Four-digit genotyping for HLA-B, HLA-DRB1 and HLA-
DQB1 was performed in 82%, 99% and 44% of the Spanish 
cohort, respectively, following quality control (QC) at Hospital 
Virgen del Rocío, Seville, Spain and Hospital Virgen de las 
Nieves, Granada, Spain.
In order to assess LD relationships, four-digit HLA-DRB1 typ-
ing was performed in a subset of the Filipino cohort of known 
genotype for the top SNP, rs9271366, where DNA was available 
(n=89). Four-digit HLA-DRB1 typing was performed in 606 of 
632 UK cases of SLE (96%). The Filipino and UK typing was 
performed at the Anthony Nolan Trust, London, UK. Two-digit 
HLA-DRB1 data were obtained for 694 of the 742 UK controls 
(92%) from the 1958 British birth cohort.
Quality control (QC) ﬁ  lters
All QC analyses except principal components analyses were per-
formed using PLINK.10 Samples and SNPs were put forward for 
analysis if they met the following quality control ﬁ  lters: SNPs 
greater than 95% genotyping efﬁ  ciency, minor allele frequency 
(MAF) >1% (failed Spanish n=271, Filipino n=758), non-devia-
tion from Hardy-Weinberg equilibrium in controls on the basis 
of a false discovery rate of 0.05 (failed Spanish n=61, Filipino 
n=21). SNPs were excluded if they showed >10% Mendel error 
rate in the post-QC Filipino trios (n=7). Samples required >95% 
genotyping efﬁ  ciency (failed Spanish n=50, Filipino n=50) and 
PI-Hat scores >0.2 on identity-by-descent analysis using ances-
try informative markers (AIMs) in order to exclude cryptic 
relatedness and duplicate samples (failed Spanish n=27, Filipino 
n=3). In order to correct for population stratiﬁ  cation, samples 
Table 1  Primary and secondary single marker association in the major histocompatibility complex region in UK, Spanish and Filipino systemic lupus 
erythematosus
SNP ID Position F_U Associated allele OR (95% CI) p Other disease Location (LD)* Gene expression¶
UK SLE
rs1269852 32188169 0.11 C 2.68 (2.16 to 3.33) 2.48×10-19 TNXB-ATF6B (760 kb)
rs3906272 31370903 0.04 A 2.84 (2.05 to 3.92) 2.95×10-10 HLA-C-HLA-B (22 kb)
rs3129868 32512355 0.11 T 1.67 (1.29 to 2.14) 8.65×10-5 BTNL2 – DRA (1501 tag SNP) 
(375 kb)
rs4713419 31101215 0.10 C 0.40 (0.25 to 0.63) 7.55×10-5 MUC21 – PSORS1C1 (9 kb) HLA-C‡
Spanish SLE
rs3130490 31847099 0.04 A 2.96 (1.95 to 4.51) 3.94×10-7 C6orf27 (620 kb)
rs3129768 32703061 0.13 C 1.91 (1.44 to 2.53) 7.57×10-6 MS BTNL2-DRA (1501 tag SNP) 
(182 kb)
rs3117213 33172583 0.18 A 1.76 (1.37 to 2.25) 7.18×10-6 ACPA+ RA CBD, 
SSc, PBC, Hep B
DPB1-DPB2 (29 kb)
rs409558 31816126 0.20 G 0.57 (0.43 to 0.77) 2.2×10-4 MSH5 (20 kb) MSH5§
Filipino SLE
rs9271366 32694832 0.34 G 2.46 (1.83 to 3.30) 1.97×10-9 MS DRB1-DQA1 (1502 tag SNP) 
(87 kb)
rs2571391 30031817 0.16 C 0.36 (0.22 to 0.59) 6.06×10-5 MS HLA-G-HLA-H (300 kb)
rs2507987 31451012 0.48 A 0.48 (0.35 to 0.66) 6.80×10-6 HLA-B-MICA (6 kb)
rs409558 31816126 0.30 G 0.56 (0.37 to 0.86) 7.47×10-3 MSH5 (100 kb) MSH5§
rs2071351 33151908 0.17 A 0.48 (0.28 to 0.83) 8.44×10-3   DPB1 (19 kb) HLA-DPB1†
Stepwise logistic regression association results are shown in italics.
Meta-analysis of Spanish and Filipino data for the MSH5 SNP rs409558 revealed a locus-wide level of signiﬁ  cance at p=1.92×10−5.
*LD surrounding each SNP calculated in control population of each cohort using r2 cut-off >0.8.
†All HapMap populations, CEU, YRI, CHB and JPT.
‡CEU and YRI only.
§CEU only.
¶Data from GEO database (http://www.ncbi.nlm.nih.gov/projects/geo/query/acc.cgi?acc=GSE6536).28
ACPA+RA, anti-citrullinated protein antibody positive rheumatoid arthritis; CBD, chronic beryllium disease; F_U, frequency in unaffected controls; Hep B, hepatitis B; LD, linkage 
disequilibrium; MS, multiple sclerosis; p, corrected/conditional p value (see Methods); PBC, primary biliary cirrhosis; SLE, systemic lupus erythematosus; SNP, single nucleotide 
polymorphism; SSc, systemic sclerosis; T1D, type 1 diabetes.
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Association of MHC class II and class III 
variants with Spanish SLE
In the Spanish cohort, 399 cases and 394 controls were put 
forward for analysis following QC measures. Logistic regres-
sion analysis of 4924 post-QC SNPs showed that the peak 
signals in this southern European SLE cohort also arise from 
the class II and class III regions of the MHC (ﬁ  gure 1, table 
1 and table S1 in online supplement). The most signiﬁ  cantly 
associated SNP, rs9268832, was located in the class II pseudo-
gene HLA-DRB9 (OR 1.80, CI 1.45 to 2.23, p=7.64×10−8) and 
showed moderate/weak LD with HLA-DRB1 alleles (ﬁ  gure 
S1 in online supplement). Serial stepwise logistic regression 
revealed a number of independent signals around HLA-DPB1 
(best SNP rs3117213) as well as risk and protective signals in 
and surrounding MSH5 (best risk SNP rs3130490; best pro-
tective SNP rs409558). Interestingly, the SNPs with the best 
OR in this Spanish dataset were the aforementioned variants 
in and around the class III genes MSH5/C6orf27. The most 
associated of these SNPs was rs3130490 (OR 3.08, CI 2.03 to 
4.66, p=1.04×10−7; (table 1, ﬁ  gure 2 and ﬁ  gure S2 in online 
supplement). This SNP showed strong LD with the top UK 
MHC SNP rs1269852 (r2=0.97). Thus, the primary MHC sig-
nal in Spanish SLE replicated that observed in the previously 
published UK dataset.5 In contrast to the UK data where the 
SNP rs3130490 showed strong LD with HLA-DRB1*03:01 
(r2=0.71), the Spanish signal showed only moderate LD 
with HLA-DRB1*03:01 (r2=0.23), suggesting that variants in 
the class III region of the MHC may play a more important 
role than previously recognised. Conditioning on rs3130490 
also revealed a number of potentially independent signals in 
the Spanish cohort, the best of which was the class II SNP 
rs3129768 located between HLA-DRB1 and HLA-DQA1 (OR 
1.91, CI 1.44 to 2.53, p=7.57×10−6). This SNP showed moder-
ate LD with HLA-DRB1*15:01 (r2=0.62). Again this contrasts 
with our northern European data where one of the main 
the standard inverse variance method. We performed tests of 
heterogeneity using the Breslow-Day test in PLINK. p values 
are represented following adjustment for the ﬁ  rst principal 
component in each dataset or following adjustment for the 
ﬁ  rst principal component and additional SNPs as covariates 
in SLR analyses in each dataset. A signiﬁ  cance threshold of 
p=7×10−5 was set, given that genome-wide signiﬁ  cance thresh-
olds based on haplotype structure are typically in the range 
of 5–7×10−8 and that the MHC region constitutes approxi-
mately 1/1000th of the genome. The LD structure of the MHC 
region has been shown to be similar to that of the genome in 
general, but there appears to be greater LD between haplo-
type blocks in the MHC region so our signiﬁ  cance threshold 
is likely to be conservative. In the Spanish cohort, separate 
logistic regression and conditional logistic regression analyses 
were performed for HLA-DRB1 alleles in order to assess rela-
tive predispositional effects. In order to account for multiple 
testing, Bonferonni-corrected p values were used as follows: 
HLA-DRB1, p=0.0023 (0.05/22 alleles tested). We examined 
LD relationships between SNPs and HLA alleles in each cohort 
by calculating the correlation coefﬁ  cient (r2) using the Tagger 
algorithm in Haploview.15
RESULTS
In all three datasets under study there was signiﬁ  cant SNP asso-
ciation across the entire MHC region (ﬁ  gure 1). The UK SLE data 
conﬁ  rmed previously published reports in northern European 
cohorts demonstrating principal SNP association within the class 
II and class III regions of the MHC.5 6 16 The most signiﬁ  cantly 
associated SNP was rs1269852, located intergenic TNXB-ATF6B 
in the class III region of the MHC. Stepwise logistic regression 
demonstrated independent association at additional MHC loci 
including SNPs tagging the HLA-DRB1*1501 haplotype in class 
II, as well as class I SNPs located between HLA-B and HLA-C 
and 5′ PSORS1C1 (table 1).
Figure 2  Primary and secondary major histocompatibility complex (MHC) region association signals in UK, Spanish and Filipino systemic lupus 
erythematosus (SLE). This ﬁ  gure shows the primary and secondary association signals in UK, Spanish and Filipino SLE denoted in blue, red and green, 
respectively. The primary signals are labelled 1 and the secondary signals obtained by stepwise logistic regression are labelled 2–5 and correspond to 
the single nucleotide polymorphism (SNPs) shown in table 1. An indication of linkage disequilibrium (LD) surrounding each marker (calculated in the 
control population of each cohort using r2 cut-off >0.8) is shown by the bars ﬂ  anking each marker. LD is <30 kb where ﬂ  anking bars are absent. The 
genomic position is shown above the plot together with the positions of the relevant MHC region genes.
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HLA-DRB1 typing in a subset of this cohort showed that the 
most highly associated SNP, rs9271366, was a perfect proxy for 
HLA-DRB1*15:02 in the Filipino population (r2=1) and suggests 
a major role for variants on this haplotype in Filipino SLE (table 
S6 in online supplement). These data are consistent with the 
known high allele frequency of HLA-DRB1*15:02 in Filipino 
reference and other Paciﬁ   c rim populations where the allele 
frequency ranges from 37% to 48%.17 18 Furthermore, the asso-
ciation of HLA-DRB1*15:01 is well established in East Asian SLE 
cohorts from Japan and Korea, while the association of HLA-
DRB1*15:02 with SLE has been reported in South East Asians 
from Thailand.19–21
SLR analyses on the top SNP (rs9271366) revealed indepen-
dent signals in the class I region of the MHC between HLA-G 
and  HLA-A (best SNP rs2571391: OR 0.36, CI 0.22 to 0.59, 
p=6.06×10−5). Further stepwise logistic regression revealed addi-
tional independent signals that replicate those observed in the 
Spanish cohort: MSH5 (best SNP rs409558) and HLA-DPB1 (best 
SNP rs2071351) (table 1 and ﬁ  gure S3 in online supplement). 
Meta-analysis of Spanish and Filipino data for the MSH5 SNP 
rs409558 revealed a locus-wide signiﬁ  cance level at p=1.92×10−5 
(ORmeta 0.58, CImeta 0.33 to 0.83).
Effect size of SNP rs9271366 is signiﬁ  cantly greater in Filipino 
SLE than in European SLE
The most associated Filipino MHC SNP, rs9271366, which acts as 
a surrogate marker for HLA-DRB1*15:02 in this population, tags 
HLA-DRB1*15:01 in populations of European ancestry (r2=0.94 (UK 
controls); r2=0.77 (Spanish controls)) and, as such, shows disease 
association in European SLE with ORs of approximately 1.4 (table 
S7 in online supplement). The frequency of HLA-DRB1*15:02 is 
low in European populations (1–2%). The SNP rs9271366 also 
tags the SNPs demonstrating disease association following pri-
mary conditional analysis in the UK (r2 with rs3129868=0.98) 
and Spanish (r2 with rs3129768=0.77) cohorts because these SNPs 
(rs3129868 and rs3129768) are also in LD with HLA-DRB1*15:01 
(table 1). As the effect size of the SNP rs9271366 is signiﬁ  cantly 
greater in the Filipino SLE cohort than in the Europeans (Filipino 
OR 2.46, European OR ~1.4, Breslow-Day p=5.25×10−4, table S7 
in online supplement), it is interesting to speculate that this genetic 
variant or variants in LD may predispose to a more severe disease 
secondary association signals was observed with variants 
in strong LD with HLA-DRB1*15:01 (r2=0.93). Further step-
wise logistic regression revealed association with the previ-
ously mentioned SNPs rs3117213 (HLA-DPB1) and rs409558 
(MSH5) (table 1). LD analysis revealed that the association 
underlying rs9268832 probably represents a composite effect 
of rs3130490 and rs3129768, resulting in its greater statistical 
signiﬁ  cance (ﬁ  gure S1 in online supplement).
MHC region SNPs show association independent 
of HLA-DRB1 alleles in Spanish SLE
Analysis of HLA-DRB1 alleles alone demonstrated principal 
association with HLA-DRB1*03:01 (OR 1.89, CI 1.43 to 2.48, 
p=5.53×10−6) (table S2 in online supplement). Conditioning 
on  HLA-DRB1*03:01 in order to assess relative predisposi-
tional effects, we found association with HLA-DRB1*15:01 
(OR 1.83, CI 1.31 to 2.55; p=0.00045). Conditioning on these 
top two HLA-DRB1 alleles, we found association with HLA-
DRB1*08:01 (OR 3.52, CI 1.55 to 8.01; p=0.0027). No other 
HLA-DRB1 alleles showed signiﬁ  cant disease association fol-
lowing further stepwise logistic regression. Next we used the 
three principally associated HLA-DRB1 alleles as covariates in 
a serial stepwise logistic regression in the entire SNP dataset. 
We found that all the aforementioned SNPs showed some 
evidence of association independent of HLA-DRB1  alleles 
except rs3129768 (table S3 in online supplement). Similar 
results were obtained when conditioning the UK SNP data 
for HLA-DRB1*03:01 and HLA-DRB1*15:01 (table S4 in online 
supplement).
Major role for MHC class II and class I variants in Filipino SLE
Following QC measures, 275 cases and 166 controls were put 
forward for analysis in the Filipino SLE cohort. The overall pat-
tern of association showed that, of the 3704 post-QC SNPs, 
the major signal arises from the class II region of the MHC and 
therefore differs from that observed in European SLE cohorts 
where principal associations are seen in class II and class III 
(ﬁ  gure 1, table 1 and table S5 in online supplement). The top 
SNP, rs9271366, was located between HLA-DRB1 and HLA-
DQA1 (OR 2.46, CI 1.83 to 3.30, p=1.97×10−9). Furthermore, 
Figure 3  Transancestral ﬁ  ne-mapping of the HLA-DRB1*15 signal in UK, Spanish and Filipino systemic lupus erythematosus (SLE). The frequencies 
of HLA-DRB1*15 alleles show geographical variability. For example, in Europeans the common allele is HLA-DRB1*15:01, in Paciﬁ  c and South East 
Asians it is HLA-DRB1*15:02, while in African populations it is HLA-DRB1*15:03 (http://allelefrequencies.net/). It is well established that haplotypes 
harbouring HLA-DRB1*15 alleles show primary or secondary association with SLE and data from this study support this view. However, the identity of 
causal variation has remained elusive due to the strong linkage disequilibrium present on the common disease-associated HLA-DRB1*15:01 haplotype 
in northern Europeans. Using the single nucleotide polymorphism (SNP) rs9271366 as a surrogate marker for the common HLA-DRB1*15 allele in each 
population studied, we have reﬁ  ned the disease-associated region from 375 kb in northern Europeans to 87 kb in the Filipino population. The latter 
region encompasses the HLA-DRB1 gene itself as well as part of the intergenic interval between HLA-DRB1 and HLA-DQA1.
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that the greater disease burden in non-European SLE populations 
may be due in part to this phenomenon. Furthermore, the fre-
quency of protective haplotypes in each population decreases 
through the same gradient (protective haplotype frequencycases 
0.525, 0.505 and 0.005, respectively).
DISCUSSION
We present the results of the ﬁ  rst high-density transancestral 
mapping study of the MHC region in SLE using cohorts from 
the UK, Spain and the Philippines. Despite the modest sample 
sizes, we have identiﬁ  ed and replicated new independent loci 
with evidence of interaction across this complex region, some 
of which appear to be SLE-speciﬁ  c (MSH5) while others suggest 
shared mechanisms across autoimmune/inﬂ  ammatory diseases 
(HLA-DPB1, HLA-G, HLA-B/C) (box 1). In particular, we were 
able to demonstrate a considerable effect from MHC variants in 
Filipino SLE using single marker and haplotypic analyses due to 
the high frequency of disease-associated variants in this cohort. 
There are no accurate prevalence data for SLE in the Philippines 
and most parts of Asia, even in the most recent literature. In 
general, published prevalence rates for SLE in Asia are broadly 
similar to those observed in Europeans and range between 30 
and 50 per 100 000.22 24 26 Interestingly, prevalence rates appear 
to be higher in Asian migrant populations.24
The primary class III risk haplotype tagged by rs1269852 
and rs3130490 in Europeans displays extended LD such that it 
encompasses most of the MHC class III region. Stepwise logistic 
regression analyses demonstrated an identical protective haplo-
type encompassing the class III gene MSH5 alone in Filipino and 
Spanish SLE. These data suggest that dysregulation of MSH5 
may underlie some of the risk attributable to the conserved class 
III risk haplotype. Further ﬁ  ne-mapping will be required to elu-
cidate the nature of this signal. The class III variants that confer 
the greatest risk in SLE cohorts of European ancestry are rare in 
Filipino and Han Chinese SLE where MAF are approximately 
0.001. These data suggest that either these variants are not 
important in SLE cohorts of south-east Asian ancestry or that dif-
ferent class III SNPs that are uncommon in Europeans and hence 
not typed in this study show association in these populations.
Two recent genome-wide association scans in SLE case-control 
cohorts of Chinese ancestry have shown that the most highly 
associated SNPs were located in the class II region of the MHC, 
between HLA-DRA and HLA-DQA2.2 3 We observed a similar 
pattern of association in the Filipino cohort under study. The 
most highly associated SNP in the Filipino cohort, rs9271366, is 
a surrogate marker for HLA-DRB1*15:02. This SNP showed the 
greatest overall association in the Hong Kong Chinese genome-
wide association study and is ranked 8 of the top 13 MHC SNPs 
in the Han Chinese genome-wide association study in SLE, 
implicating HLA-DRB1*15:02 haplotypes in SLE susceptibility in 
these populations as well.
phenotype such as renal involvement, as is often observed in non-
European populations.22–24
Reﬁ  nement of SLE-associated HLA-DRB1*15 signal
Previous attempts to ﬁ   ne-map the SLE-associated HLA-
DRB1*1501 haplotypic signal could only delimit the region to 
approximately 500 kb of the MHC class II region in European-
Americans using microsatellite typing.25 When the SNP 
rs9271366 was used as a surrogate marker for HLA-DRB1*15 
haplotypes, we found that the LD surrounding this SNP varied 
in the different populations studied from a 375 kb region in UK 
SLE to a 182 kb region in Spanish SLE and to an 87 kb region 
encompassing HLA-DRB1 and the intergenic interval between 
HLA-DRB1 and HLA-DQA1 in Filipino SLE (ﬁ  gure 3). Hence, 
the transancestral mapping approach used in this study allowed 
reﬁ  nement of the SLE-associated HLA-DRB1*15 signal.
Evidence for genetic interaction between the top independent 
MHC region SNPs in SLE
Haplotypic analyses were performed on the top three indepen-
dent SNPs from each cohort to look for evidence of interaction. 
The top SNP was chosen from each cohort, together with the 
next two independently associated SNPs which were selected 
following stepwise logistic regression (table 2). Despite the rela-
tively modest cohort sizes, these analyses suggested evidence of 
genetic interaction (non-additive effects) in all three populations 
studied (table S8 in online supplement). For example, in the 
Spanish cohort, a multiple logistic regression model was ﬁ  tted 
using the top three independent SNPs (rs3130490, rs3129768 and 
rs3117213) as explanatory variables and interaction terms were 
tested for. Interestingly, the best model (difference in Akaike 
Information Criterion=4.8, difference in Bayesian Information 
Criterion=6.8) had an rs3130490*rs3129768 interaction where 
the effect on the OR was positive (5.1 (95% CI 1.12 to 23.08), 
p=0.03), plus an independent additive term for rs3117213 (see 
table S9 and ﬁ  gure S4 in online supplement).
Increased frequency of MHC region risk alleles and haplotypes 
in Filipino SLE compared with European SLE
Next we examined haplotypic frequency and association using 
the top three independent SNPs in all three cohorts studied (table 
2). We found that the haplotype harbouring the risk alleles of the 
top three SNPs was rare in European SLE cohorts. However, in 
Filipino SLE, the risk haplotype was common while the protective 
haplotype was rare (risk OR 3.45, CI 2.24 to 5.33, p=5.69×10−11; 
protective OR 0.002, CI 1×10−4 to 0.05, p=2.10×10−4). Thus, the 
population frequency of the top ranked risk alleles and risk haplo-
types increases from the UK and Spain to the Philippines (risk hap-
lotype frequencycases 0, 0.004 and 0.273, respectively), suggesting 
Table 2  Haplotypic association using the top three SNPs following serial step-wise logistic regression in each cohort is shown (see table 1 and table 
s8 in the online supplement for further details).
  SNP1 SNP2 SNP3 HAPLOTYPE F_A F_U F_Uexp OR 95% CI p pperm
UKrisk rs1269852 rs3906272 rs3129868 CAT <0.001 <0.001 0.0004 NA NA NA NA
UKprot rs1269852 rs3906272 rs3129868 GGG 0.524 0.729 0.7604 0.37 0.31 to 0.44 3.72×10−28 1×10−4
Spanishrisk rs3130490 rs3129768 rs3117213 ACA 0.004 <0.001 0.001 NA NA NA NA
Spanishprot rs3130490 rs3129768 rs3117213 CAC 0.506 0.688 0.6849 0.443 0.36 to 0.55 2.22×10−13 1×10−4
Filipinorisk rs9271366 rs2571391 rs2507987 GAT 0.273 0.092 0.1485 3.45 2.24 to 5.33 5.69×10−11 1×10−4
Filipinoprot rs9271366 rs2571391 rs2507987 ACA 0.005 0.031 0.0507 NA NA NA NA
F_A, haplotypic frequency in affected SLE cases; F_U, haplotypic frequency in unaffected controls; F_Uexp, expected haplotypic frequency calculated from minor allele frequency 
of SNPs in controls; NA, not applicable (unable to perform statistical analyses as frequencies too low); p, p value; pperm, permuted p value (10000 permutations); prot, haplotype 
comprising all three protective alleles; risk, haplotype comprising all three risk alleles; SLE, systemic lupus erythematosus; SNP, single nucleotide polymorphism.
25_annrheumdis-2011-200808.indd   782 25_annrheumdis-2011-200808.indd   782 3/30/2012   7:03:32 PM 3/30/2012   7:03:32 PMBasic and translational research
Ann Rheum Dis 2012;71:777–784. doi:10.1136/annrheumdis-2011-200808 783
SLE. These signals are independent of each other and HLA-DRB1 
alleles and show some evidence of genetic interaction. These 
data highlight the usefulness of mapping disease susceptibility 
loci using a transancestral approach, particularly in a region as 
complex as the MHC, and offer a springboard for further ﬁ  ne-
mapping, resequencing and transcriptomic analysis.
Using transancestral SNP mapping of the MHC region in SLE, 
we have successfully reﬁ   ned the established SLE-associated 
HLA-DRB1*15 signal to an interval encompassing HLA-DRB1 
and HLA-DQA1. We have identiﬁ  ed and replicated association 
in the genes MSH5 and HLA-DPB1 in Filipino and Spanish SLE 
cohorts, and also demonstrated association at HLA-G in Filipino 
Box 1  Major histocompatibility complex region susceptibility genes and haplotypes in 
systemic lupus erythematosus
▶   HLA-DPB1: For the ﬁ  rst time we report an association with single nucleotide polymorphisms 
(SNPs) in the region of HLA-DPB1 and systemic lupus erythematosus (SLE). The most associated 
SNP in this region is rs3117213, located between the pseudogenes HLA-DPA2 and COL11A2P. This 
SNP has previously shown association with ACPA-positive rheumatoid arthritis (RA) in northern 
European cohorts and is independent of the known RA HLA-DRB1 risk alleles.29 30 The association 
of HLA-DPB1 alleles with chronic beryllium disease is well established.31 Recent studies have 
also detected associations in the HLA-DPB1 region with chronic hepatitis B infection, Wegener’s 
granulomatosis, primary biliary cirrhosis, Graves’ disease, Takayasu’s arteritis, juvenile idiopathic 
arthritis, systemic sclerosis and multiple sclerosis in European and non-European populations.29 
32–36 The association of this region with these autoimmune, infectious and inﬂ  ammatory diseases 
suggests that it is likely to represent a shared autoimmune/inﬂ  ammatory locus.
▶   MSH5: The MSH5 (MutS homologue 5) gene, located in the major histocompatibility complex 
(MHC) class III region, comprises 26 exons and spans 25 kb.37 MSH5 belongs to a family of 
proteins involved in DNA mismatch repair and meiotic recombination. Recent evidence also 
suggests a role for human MSH5 in promoting ionising radiation-induced apoptosis.38
▶   HLA-G: The principal signal after stepwise logistic regression analysis on the top Filipino SNP 
rs9271366 is observed in the class I region of the MHC between HLA-G and HLA-H. HLA-H is 
transcribed but not translated. HLA-G is a non-classical HLA class I molecule that has been 
implicated in immune tolerance mechanisms and autoimmune disease.39 Unlike other classical HLA 
molecules, HLA-G exhibits limited nucleotide and protein polymorphism and shows marked tissue 
restriction in that the molecule is primarily expressed on cytotrophoblastic cells of the placenta 
where it is thought to mediate maternal-fetal tolerance40 41 (http://hla.alleles.org/proteins/class1.
html). HLA-G expression can be induced in tumours, transplanted tissue and plaques from patients 
with multiple sclerosis. HLA-G is able to suppress immune responses through binding inhibitory 
receptors such as ILT2, ILT4 and KIR2DL4 which are expressed on a variety of immune cells including 
NK cells (KIR2DL4), CD4+ and CD8+ T cells, B cells, monocytes and dendritic cells.41 Recent 
studies in multiple sclerosis and SLE have suggested HLA-G as a putative disease susceptibility 
gene.39 A 14 bp insertion located in the 3′UTR of the gene has been associated with lower levels of 
HLA-G mRNA. Interestingly, the HLA-G*01:01:02 allele which is the most common allele carrying the 
14 bp insertion shows strong linkage disequilibrium with the SLE-associated HLA-A*01-HLA-B*08-
HLA-DRB1*03-HLA-DQA1*05-HLA-DQB1*02 haplotype in European populations.42
▶   RCCX module: The MHC class III risk haplotype, tagged by rs1269852 and rs3130490 showing 
primary association in the Spanish cohort, spans the copy variable RCCX module containing 
complement component C4. A similar haplotype, also extending across the RCCX module, 
harbours the most highly associated SNPs in our northern European SLE cohort.5 Despite the 
haplotypic diversity observed in the southern European Spanish population compared with 
northern Europeans, we have not been able to ﬁ  ne-map this signal using SNPs. The reasons 
underlying the conservation of this haplotype remain unclear but include selective pressures and 
co-regulation of gene expression.
▶   HLA-DRB1*15 alleles: The HLA-DRB1*15:01 and HLA-DRB1*15:02 alleles, which show 
association in European and Filipino SLE respectively, differ by only one amino acid—a valine 
(DRB1*15:01) to glycine (DRB1*15:02) substitution at position 86 of the amino acid sequence in 
pocket P1 of the peptide-binding cleft.43 Haplotypes harbouring HLA-DRB1*15:01 alleles confer 
risk for SLE and multiple sclerosis but also demonstrate protection in diseases such as type 1 
diabetes and IgA deﬁ  ciency.4 5 The mechanisms underlying these phenomena are unknown.
▶   HLA-C / HLA-B region: Data from the Filipino and UK SLE cohorts under study reveal association in 
the class I region of the MHC encompassing HLA-C/HLA-B/MICA. A recent genome-wide association 
study comparing HIV-1 controllers and progressors found that the same region harbours the major 
genetic determinants of HIV-1 control. Further analysis implicated speciﬁ  c HLA-B allele peptide 
groove amino acids, in addition to an independent HLA-C effect in the control of HIV infection.44
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